Refine by
Clinics Hospitals Articles & Analysis
216 news found
This acquisition brings together two complementary players in the market: Bertin Medical Waste, recognized for its compact in situ solutions for hospitals and clinics, and Ecosteryl, a leader in high-capacity industrial solutions. ...
Following regulatory approval, Advanced Instruments, a wholly-owned subsidiary within Patricia Industries, has now completed its acquisition of Nova Biomedical, a global provider of analytical instruments and consumables for the biopharmaceutical and clinical markets. The enterprise value amounts to USD 2.2bn. Patricia Industries has contributed USD 1.6bn in financing. The remainder of the ...
Patricia Industries’ subsidiary Advanced Instruments, a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, today announced the execution of a definitive agreement to acquire Nova Biomedical, a manufacturer of innovative analytical instruments and consumables that are vital in guiding the treatment of patients and the development of ...
These are crucial tasks as the Centers for Disease Control and Prevention (CDC) reports that on any given day, about 1 in 31 patients receiving care in a hospital has at least one healthcare-associated infection (HAI). For nursing home residents, CDC shares that about 1 in 43 has at least one infection in association with their healthcare. ...
These are crucial tasks as the Centers for Disease Control and Prevention (CDC) reports that on any given day, about 1 in 31 patients receiving care in a hospital has at least one healthcare-associated infection (HAI). For nursing home residents, CDC shares that about 1 in 43 has at least one infection in association with their healthcare. ...
With projections extending through 2028, the study encompasses key market players and scrutinizes medical kiosks across types (check-in, payment, way-finding, telemedicine, self-service, and others) and end-users (hospitals, clinics, laboratories, pharma stores, and others). A meticulous regional breakdown covers North America, Europe, Asia-Pacific, and the Rest ...
” Bjöern von Siemens, co-founder and CFO: “2023 has been a particularly successful chapter in our decade-long journey, marked by growing our GAAP revenue by 100 percent, showing clear financial and clinical ROI on hospital level and forging impactful value partnerships with our clients. Through these partnerships with industry leaders, we have ...
“This announcement is very important for hospital decision-makers, government agencies, and anyone considering UV technology to understand. ...
Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces five new hospitals have implemented the Company’s BVA-100 blood volume diagnostic for clinical use to guide fluid management in heart failure patients during the first quarter of 2023. The addition of these hospitals contributes to the ...
Clinical Trial Manager roles are growing 32% faster than the national average. ...
Our devices are valued in many hospitals, medical offices, clinics, and pharmacies all over the world. ...
Rüdiger Rupp, a key opinion leader in the field of rehabilitation technology with more than 25 years of clinical experience, to talk about rehabilitation, exoskeleton technology, clinical trials and many more. ...
The production is performed at the hospital utilizing the Orgenesis Mobile Processing Units and Lab (OMPUL) to supply clinical grade batches. ...
We are pleased to announce that “EngageABLE”, a project of ABLE Human Motion in collaboration with the dutch hospital Sint Maartenskliniek, has been awarded for funding by DIH-HERO. ...
We performed 2 clinical trials in leading neurorehabilitation hospitals in Germany and Spain proving safety, feasibility and usability of the exoskeleton in a clinical setting, and showing significant improvements in clinical outcomes and benefits in rehabilitation. A Multicentric Clinical investigation in ...
During the economic crisis, if customers lose their jobs, they may also lose their medical insurance, which means that they will be difficult to provide medical and health services. In this case, the dentist or clinic is more important than ever to reduce costs, so that they can pass on much of the saved costs to customers. One of the best ways is to buy high-quality wholesale ...
With plans for expansion across Ardent’s 30 hospitals, the program also leverages BioIntelliSense’s FDA-cleared AlertWatch, clinical intelligence and triage solution. ...
Exclusive global license for CORE NK platform (CHM 0201) executed with Case Western Reserve University in Ohio Initial Phase 1 clinical trial results of the CORE NK platform (CHM 0201) were published demonstrating safety and encouraging activity in blood cancers and solid tumours One patient achieved a complete response that was sustained for over 15 months at time of ...
Our clinicians eagerly anticipate the opportunity to initiate the first clinical trial in Europe using an in-hospital, accelerator-based neutron beam developed for this purpose. ...
The Simeox device is an efficient and comfortable therapy for distal mucus clearance – for patients suffering from chronic lung conditions associated with chest congestion, such as bronchiectasis, cystic fibrosis, COPD, primary ciliary dyskinesia, severe asthma, etc. It can be used in the hospital or clinics, or autonomously at home. The equation for ...